Physician profile
William D Boyd
NPI 1649230244
$1,136.55
in general payments reported to CMS, 2019-2025
27 companies · $94.16 in 2025
The $94.16 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $349 · 2020: $54.84 · 2021: $35.22 · 2022: $256 · 2023: $273 · 2024: $73.78 · 2025: $94.16.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $441.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $441.22 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $187.83 | 2019-2025 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $146.99 | 2019-2025 | |
| Aspira Women'S Health INC | $106.63 | 2019 | |
| Pfizer INC. | $76.62 | 2019-2024 | |
| Mayne Pharma Commercial LLC | $66.15 | 2022-2023 | |
| Therapeuticsmd, INC. | $64.19 | 2019-2022 | |
| Sumitomo Pharma America, INC. | $60.07 | 2023 | Myfembree |
| Abbvie INC. | $51.68 | 2019-2022 | |
| Hologic Sales and Service, LLC | $41.10 | 2021-2022 | |
| Myovant Sciences INC. | $36.35 | 2022 | |
| Coopersurgical, INC. | $28.72 | 2022 | |
| Merck Sharp & Dohme LLC | $27.83 | 2020-2023 | Gardasil 9 |
| Exact Sciences Corporation | $23.54 | 2023 | Cologuard Collection Kit |
| Pacira Pharmaceuticals Incorporated | $23.24 | 2019 | |
| Covidien LP | $19.96 | 2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Minerva Surgical, INC | $17.97 | 2025 | |
| Ferring Pharmaceuticals INC. | $17.78 | 2019 | |
| Vertical Pharmaceuticals, LLC | $16.70 | 2019 | |
| Lupin INC. | $16.54 | 2019 | |
| Millicent US INC | $16.31 | 2024 | Intrarosa, Femring |
| Lsi Solutions INC | $16.25 | 2023 | Ti Knot, Fornisee, Running Device |
| Exeltis, USA INC. | $15.91 | 2024 | Slynd |
| Intuitive Surgical, INC. | $14.90 | 2023 | Da Vinci Surgical System |
| Scynexis, INC. | $12.68 | 2022 | |
| Organon LLC | $11.97 | 2023 | Nexplanon |
| Allergan, INC. | $11.84 | 2019 | |
| Allotrope Medical, INC | $6.80 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Boyd listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.